← Back to All Filings

Vanguard Group Reports 0% Direct Reporting Stake in Cardinal Health

Low SignificanceMarch 26, 2026 at 4:44:50 PM EDT

CARDINAL HEALTH INC

$CAHSCHEDULE 13G/ACIK: 0000721371

Subscribe to track CAH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Vanguard Group Reports 0% Direct Reporting Stake in Cardinal Health

Company: Cardinal Health Inc Form: SCHEDULE 13G/A | Filed: 2026/03/26 Significance: Low (Administrative)

Insider: The Vanguard Group Title: Investment Adviser | Relationship: Institutional Investor

Transaction: • Type: Internal Realignment • Shares: N/A • Price: N/A • Value: N/A • Owned After: 0

Key Insight: Vanguard reports 0 shares due to internal realignment; subsidiaries will now report beneficial ownership separately.

Market Context: This is a technical reporting change rather than a liquidation of assets by Vanguard funds.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: Cardinal Health Inc

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Vanguard Group has restructured its reporting, resulting in the parent company showing 0% ownership while subsidiaries will report separately.
  • Market Impact: Neutral - This is an administrative change, not a market liquidation.

Company Information

FieldValue
CompanyCardinal Health Inc
CIK0000721371
IndustryWholesale-Drugs Proprietaries & Druggists' Sundries
Market Cap$48.93 Billion

Insider Information

FieldValue
NameThe Vanguard Group
CIK0000102909
Title/PositionInvestment Adviser
RelationshipInstitutional Investor

Transaction Details

FieldValue
Form TypeSCHEDULE 13G/A
Transaction Date03/13/2026 (Event Date)
Transaction CodeN/A
Security TypeCommon Stock
Shares InvolvedN/A (Status Report)
Price Per ShareN/A
Total ValueN/A
Shares Owned After0
Ownership TypeN/A

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction ValueN/A
% of Market CapN/A
Shares TransactedN/A
% of Shares OutstandingN/A
Post-Transaction Ownership0 shares (0% of outstanding)
Materiality AssessmentLow (Administrative)

Impact Evaluation

  • Market Cap Context: Cardinal Health is a Large Cap company ($48.93B). Institutional holdings are typically significant, but this specific filing represents a change in reporting structure rather than a change in investment thesis.
  • Ownership Concentration: The filing indicates the parent entity (The Vanguard Group, Inc.) no longer holds the securities directly for reporting purposes.
  • Transaction Significance: While the ownership drops to 0%, the explanatory note clarifies that subsidiaries now report separately. This prevents double-counting or misinterpretation of centralized ownership.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The filing contains a specific footnote stating: "The Vanguard Group, Inc. went through an internal realignment... certain subsidiaries... will report beneficial ownership separately." This confirms no actual sell-off occurred.

Volume & Sentiment

  • Expected Volume Impact: Negligible.
  • Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

  • Special Circumstances: The filing cites SEC Release No. 34-39538 regarding the disaggregation of business divisions. This is a compliance-driven filing.
  • Timing: Filed on March 26, 2026, with an event date of March 13, 2026.
Topics:#SECFiling#CardinalHealth#Vanguard#InstitutionalHoldings#Form13G#StockMarket#Investing#FinancialNews#MarketAnalysis#RegulatoryFiling

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.